Key result
Higher adiponectin levels are linked to lower CAD atherosclerotic burden in nondiabetic patients.
Why the study?
The association of plasma adiponectin levels with coronary artery disease, hypertension, and insulin resistance in nondiabetic patients was unclear.
Are plasma adiponectin levels associated with coronary artery disease severity, hypertension, and insulin resistance in high-risk nondiabetic patients?
Cross-Sectional (n=400)
Are plasma adiponectin levels associated with coronary artery disease severity, hypertension, and insulin resistance in high-risk nondiabetic patients?
Low plasma adiponectin is associated with increased coronary artery disease severity and insulin resistance, but not hypertension, in high-risk nondiabetic patients.
Answers are grounded in this paper and cite their sources.
Low adiponectin marks greater CAD burden independent of hypertension; leaves open its value as a biomarker pending prospective validation.
OBJECTIVE: To investigate the association of plasma adiponectin levels with coronary artery disease (CAD), arterial hypertension (HT), and insulin resistance (IR) in nondiabetic Caucasian patients. DESIGN: We measured plasma adiponectin levels, IR (HOMA index), and the CAD atherosclerotic burden (angiography-based modified Duke Index score) in 400 nondiabetic patients undergoing coronary angiography. HT was diagnosed by the European Society of Hypertension/European Society of Cardiology (ESH/ESC) guidelines or if patients were on antihypertensive treatment. RESULTS: Coronary artery disease was found in 62% of the patients and ruled out in the rest (non-CAD group). Plasma adiponectin levels were inversely related to the CAD score (beta = -0.12, P = 0.029) and predicted the coronary atherosclerotic burden independent of other cardiovascular risk factors. However, they were similar in NT and HT and showed no correlation with blood pressure values. In non-CAD, but not in CAD patients, they were lower in patients with than without IR (8.3 +/- 1.2 vs. 11.3 +/- 1.3, respectively; P = 0.007). CONCLUSIONS: In nondiabetic high-risk Caucasian patients plasma adiponectin levels are inversely related to CAD severity and IR; however, they are not strongly related to blood pressure values.
No takes yet. Share an insight, caveat, or question.
Cesari et al. (2006) conducted a cross-sectional in Coronary artery disease, hypertension, and insulin resistance (n=400). Plasma adiponectin levels was evaluated on Coronary artery disease atherosclerotic burden (angiography-based modified Duke Index score) (beta = -0.12, p=0.029). Plasma adiponectin levels were inversely related to the coronary artery disease atherosclerotic burden in nondiabetic Caucasian patients.
Synapse has enriched 10 related papers. Consider them for comparative context: